These drugs are commonly known by brand names including Wegovy, Ozempic, and Mounjaro, but what's more important are the active ingredients: semaglutide, liraglutide, exenatide, and dulaglutide were the four examined here
Lillys Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease 2025 [Press release]
We have a chance to get this right
The growth of telemedicine has expanded access for many, but it also raises concerns about fragmented care, inconsistent follow-up and variable quality of counseling
What does GLP-1 friendly mean